What Is the Tzagournis Medical Research Facility?
The Tzagournis Medical Research Facility (TMRF) is a multidisciplinary research campus located in Thessaloniki, Greece, dedicated to biomedical and clinical studies. Established in 2015, the facility brings together academic institutions, private industry partners, and government agencies to accelerate translational research.
More from this site
Keep reading the latest coverage
Historical Background and Founding Vision
The facility was founded by Dr. Maria Tzagournis, a renowned cardiologist and researcher, who envisioned a hub where basic science could be rapidly converted into clinical applications. The project received initial seed funding from the Greek Ministry of Health and private donors, allowing the construction of state‑of‑the‑art laboratories and patient care units.
Research Focus Areas
TMRF concentrates on five primary domains:
- Cardiovascular disease and regenerative medicine
- Neurodegenerative disorders and brain imaging
- Oncology and precision medicine
- Infectious disease surveillance and vaccine development
- Pharmacogenomics and personalized therapy
Cardiovascular Innovation
One of the flagship programs is the Cardiac Regeneration Initiative, which studies stem cell therapies to repair damaged heart tissue. Clinical trials are underway in collaboration with the National Hospital of Thessaloniki.
Neuroimaging Center
The Neuroimaging Center employs advanced MRI and PET scanners to map disease progression in Alzheimer's and Parkinson's patients.
Infrastructure and Facilities
TMRF spans 30,000 square meters, featuring:
- High‑throughput genomics lab
- Biobank with over 50,000 de‑identified samples
- Clinical trial units with inpatient and outpatient capabilities
- Digital health analytics platform
Funding and Partnerships
Funding streams include:
| Source | Contribution | Notes |
|---|---|---|
| Greek Ministry of Health | €12M (initial) | Infrastructure |
| European Union Horizon 2020 | €18M | Research grants |
| Private Investors | $5M | Equipment |
| Pharmaceutical Partners | Variable | Collaborative trials |
Impact and Achievements
Since inception, TMRF has:
- Published 250 peer‑reviewed papers
- Licensed 3 drug candidates to clinical development
- Trained over 200 PhD students and postdocs
- Contributed to national health policy on personalized medicine
Future Directions
Planned expansions include a dedicated AI research wing and a global data-sharing consortium to enhance disease modeling.
How to Get Involved
Researchers can apply for grants via the TMRF portal. Patients may enroll in ongoing trials by contacting the clinical services office.